Epithelial ovarian cancer accounts for 85%-90% of ovarian malignant tumors. The early diagnosis is difficult. Epithelial ovarian cancer has various metastasis ways
high recurrence rate and poor prognosis.
18
F-fluorodeoxyglucose (
18
F-FDG) PET/CT molecular imaging provides the information of both anatomical structure and glucose metabolism and has unique advantages in differential diagnosis of benign and malignant epithelial ovarian tumors
staging
curative effect prediction
prognosis judgment
recurrence diagnosis and treatment guide.
18
F-FDG PET/CT imaging is widely applied in epithelial ovarian cancer.